SCHEMBL7488125

SCHEMBL7488125

CCOC(=O)N1CCCc2ccc(C(=O)CBr)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.44
KDM4E B2RXH2 2/20 0.44
GNG2 P59768 1/20 0.44
GNB1 P62873 1/20 0.44
ALDH1A1 P00352 5/20 0.43
MAPT P10636 3/20 0.43
HSD17B10 Q99714 1/20 0.43
HPGD P15428 2/20 0.41
LMNA P02545 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
TSHR P16473 2/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
IDO1 P14902 1/20 0.40
KCNH2 Q12809 1/20 0.40
OGG1 O15527 1/20 0.40
KMT2A Q03164 2/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7487677 0.86 TP53 (0.52) TP53KDM4EALDH1A1MAPTHSD17B10
SCHEMBL7486918 0.82 ALDH1A1 (0.60) TP53KDM4EALDH1A1MAPTHSD17B10
SCHEMBL7830913 0.77 CNR2 (0.47) KDM4EALDH1A1MAPTHPGDNPSR1
SCHEMBL5423338 0.76 KDM4E (0.51) KDM4EALDH1A1MAPTHSD17B10HPGD
SCHEMBL7830713 0.76 KDM4E (0.52) KDM4EALDH1A1MAPTHSD17B10HPGD
SCHEMBL5426108 0.76 NOTUM (0.65) ALDH1A1MAPTHPGDTSHRPOLB
SCHEMBL10856983 0.76 NOTUM (0.56) TP53KDM4EALDH1A1MAPTHPGD
SCHEMBL8790990 0.75 TP53 (0.52) TP53KDM4EALDH1A1MAPTHSD17B10
SCHEMBL5423637 0.74 PDK1 (0.49) TP53KDM4EALDH1A1MAPTHSD17B10
SCHEMBL14500666 0.74 ALDH1A1 (0.49) KDM4EALDH1A1MAPTHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1065204-B1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER (US) 2002-04-10 EP disclosed
US-6303628-B1 FOR THE TREATMENT OF A MEDICAL CONDITION IN WHICH PROSTAGLANDINS ARE IMPLICATED AS PATHOGENS IN MAMMALS PFIZER INC 2001-10-16 US disclosed
EP-1065204-A1 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents and as COX-2 inhibitors PFIZER INC. (US) 2001-01-03 EP disclosed